Roberto Patarca – författare

Because of the individual and varying symptoms of chronic fatigue syndrome, medical guidelines encompassing the needs of every patient simply do not exist. Through proven research and recommendations for future treatment, Disability and Chronic Fatigue Syndrome: Clinical, Legal, and Patient Perspectives discusses the difficult subject of how to diagnose disability in chronic fatigue syndrome patients, how to determine the severity of a patient’s disability, and how new disability guidelines would make more chronic fatigue patients eligible to apply for disability benefits. From this information, you will gain a clearer understanding of chronic fatigue syndrome, enabling you to more accurately assess a patient’s condition or decide if your client is eligible for disability benefits. Essential for clinicians, lawyers, patients, and medical insurers, Disability and Chronic Fatigue Syndrome provides an outline of disability guidelines established by the Social Security Administration (SSA), the Veterans’Administration, and the American Medical Association, as well as federal guidelines. While gaining information on the different types of disability insurance available to chronic fatigue patients, such as the Long Term Disability (LTD) policy, you will also learn how standard procedures such as psychiatric evaluation, neuropsychological testing, and physical capacity measurement can both help and hinder the process of determining disability in a patient. In addition, Disability and Chronic Fatigue Syndrome provides insight into:the symptoms of chronic fatigue syndrome, such as inability to work and level of stamina, in accordance with medical and legal definitions disability guidelines set by the SSA how patients’varying symptoms and conflicting findings affect disability diagnosis in chronic fatigue syndrome patients by SSA standards plans by the Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) Association of America to work with the SSA concerning strategies to dissolve barriers to Social Security Disability Income Benefits for patients and to advocate for up-to-date information on CFIDS in the SSA’s Listing of Impairments. tips on applying for SSA benefits claims that insurance companies have used misleading surveillance videos and fraud to discontinue disability benefits to patients in need of coverage Since the Social Security Administration does not currently consider a CFIDS diagnosis enough to win a disability claim, Disability and Chronic Fatigue Syndrome also contains many recommendations for improving federal disability guidelines, such as using results from functional evaluations, neuropsychological testing, and exercise endurance testing as evidence of impairment. For less severe cases, this book provides you with suggestions for rehabilitation of CFS patients before disability claims are made, including patient training and education, dependency counseling, muscular conditioning, and occupational therapy. Whether you are a patient, clinician, lawyer, or medical insurer, Disability and Chronic Fatigue Syndrome will guide you through the complex issues surrounding disability and this intricate disease.

Because of the individual and varying symptoms of chronic fatigue syndrome, medical guidelines encompassing the needs of every patient simply do not exist. Through proven research and recommendations for future treatment, Disability and Chronic Fatigue Syndrome: Clinical, Legal, and Patient Perspectives discusses the difficult subject of how to diagnose disability in chronic fatigue syndrome patients, how to determine the severity of a patient’s disability, and how new disability guidelines would make more chronic fatigue patients eligible to apply for disability benefits. From this information, you will gain a clearer understanding of chronic fatigue syndrome, enabling you to more accurately assess a patient’s condition or decide if your client is eligible for disability benefits. Essential for clinicians, lawyers, patients, and medical insurers, Disability and Chronic Fatigue Syndrome provides an outline of disability guidelines established by the Social Security Administration (SSA), the Veterans’Administration, and the American Medical Association, as well as federal guidelines. While gaining information on the different types of disability insurance available to chronic fatigue patients, such as the Long Term Disability (LTD) policy, you will also learn how standard procedures such as psychiatric evaluation, neuropsychological testing, and physical capacity measurement can both help and hinder the process of determining disability in a patient. In addition, Disability and Chronic Fatigue Syndrome provides insight into:the symptoms of chronic fatigue syndrome, such as inability to work and level of stamina, in accordance with medical and legal definitions disability guidelines set by the SSA how patients’varying symptoms and conflicting findings affect disability diagnosis in chronic fatigue syndrome patients by SSA standards plans by the Chronic Fatigue Immune Dysfunction Syndrome (CFIDS) Association of America to work with the SSA concerning strategies to dissolve barriers to Social Security Disability Income Benefits for patients and to advocate for up-to-date information on CFIDS in the SSA’s Listing of Impairments. tips on applying for SSA benefits claims that insurance companies have used misleading surveillance videos and fraud to discontinue disability benefits to patients in need of coverage Since the Social Security Administration does not currently consider a CFIDS diagnosis enough to win a disability claim, Disability and Chronic Fatigue Syndrome also contains many recommendations for improving federal disability guidelines, such as using results from functional evaluations, neuropsychological testing, and exercise endurance testing as evidence of impairment. For less severe cases, this book provides you with suggestions for rehabilitation of CFS patients before disability claims are made, including patient training and education, dependency counseling, muscular conditioning, and occupational therapy. Whether you are a patient, clinician, lawyer, or medical insurer, Disability and Chronic Fatigue Syndrome will guide you through the complex issues surrounding disability and this intricate disease.

Offering a thorough, accessible overview of the basic science and clinical data regarding the virus that causes COVID-19, Molecular Biology of SARS-CoV-2 is an excellent resource for researchers, clinical scientists, physicians, and students. This volume offers in-depth, extended content that originated with Drs. Roberto Patarca’s and William A. Haseltine’s chapter in The COVID-19 Textbook, edited by Dr. Haseltine and Dr. Patarca. The greatly expanded material in this text provides a much-needed primer in this complex area.   Reviews the basic science, clinical data and various perspectives on how SARS-CoV-2 infects cells, replicates, manipulates cellular machinery, evades host defenses, and is transmitted to other hosts Covers the origin and structure of SARS-CoV-2, followed by chapters based on the life cycle of the virusProvides a thorough review of what is known for each molecular component of the viral life cycle while incorporating information on pertinent prevention and therapeutic interventions  About the Authors  Roberto Patarca, MD, PhD  Dr. Patarca is the Chief Medical Officer at ACCESS Health International and a former pharmaceutical and medical device company executive and faculty at Harvard Medical School and the University of Miami. His research has focused on the AIDS virus, microbial replication regulation, adoptive cellular immunotherapy, drug resistance testing, cardiovascular interventions, and chronic fatigue syndrome.  He served on Advisory Committees to two U.S. Secretaries of Health and Human Services, was elected to the Academy of Sciences of Latin America; worked with the World Health Organization on standardization of cytokine level measurements, and has been published widely.William A. Haseltine, PhD  In Dr. Haseltine’s career at the forefront of medical research and application, he has educated a generation of doctors at Harvard Medical School, designed the strategy to develop the first treatment for HIV/AIDS, is well-known for his groundbreaking work on cancer, and led the team that pioneered the development of new drugs based on information from the human genome.  He is the author of more than two hundred peer-reviewed manuscripts and fifteen books. As Chair and CEO of ACCESS Health International, Dr. Haseltine is dedicated to ensuring that advances in medical technology translate to improved health outcomes worldwide.